Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System Read More » 16 July 2026
Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina® EZFuse system Read More » 17 March 2026